| 41/102 | US=64 / Câncer Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4. MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 42/102 | US=64 / Câncer Langston AA, Francis D. Epidemiology of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 9-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 43/102 | US=64 / Câncer Raab MS, Anderson KC. Basic biology of plasma cell dyscrasias: focus on the role of the tumor microenvironment. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 23-39. (Comtemporary Hematology) ISBN 978-1-934115-82-4. BIOLOGIA BASICA DAS CELULAS PLASMATICAS DISCRASIAS; PAPEL DO MICROAMBIENTE TUMORAL |
| 44/102 | US=64 / Câncer Chng WJ, Bergsagel PL. Biology-based classification and staging of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 41-56. (Comtemporary Hematology) ISBN 978-1-934115-82-4. BIOLOGIA BASEADA EM MIELOMA MULTIPLO; ESTADIAMENTO DO MIELOMA MULTIPLO |
| 45/102 | US=64 / Câncer Braggio E, Sebag M, Fonseca R. Cytogenetic abnormalities in multiple myeloma: the importance of FISH and cytogenetics. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 57-76. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 46/102 | US=64 / Câncer Harousseau JL. Role of autologous stem cell transplantation in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 79-90. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TRANSPLANTE AUTOLOGO DE CELULAS-TRONCO NO MIELOMA MULTIPLO; TERAPIA DE ALTA DOSE; HDT; AUTOLOGO TRANSPLANTE DE CELULAS ESTAMINAIS |
| 47/102 | US=64 / Câncer Kaufman JL, Mihelic R, Lonial S. Maintenance therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 91-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 48/102 | US=64 / Câncer Sara B, Antonio P. Therapy for patients not eligible for autologous transplant. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 99-112. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPIA PARA PACIENTES NAO COMPATIVEL TRANSPLANTE; TRANSPLANTE AUTOLOGO; QUIMIOTERAPIA CONVENCIONAL |
| 49/102 | US=64 / Câncer Ailawadhi S, Chanan-Khan A. Current role of anthracyclines in the treatment of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 113-21. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TRATAMENTO DO MIELOMA MULTIPLO. ANTRACICLINAS; ANTRACICLINAS |
| 50/102 | US=64 / Câncer Wang F, Waller EK. Allogeneic transplantation for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 125-42. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TRANSPLANTE ALOGENICO DE MIELOMA MULTIPLO; CLONAL DE CELULAS B; IMUNOTERAPIA ANTI MIELOMA |
| 51/102 | US=64 / Câncer Munshi NC, Tai YT. Antibody and other immune-based therapies for myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4. ANTICORPOS; IMUNO-TERAPIAS BASEADAS PARA MIELOMA; ANTICORPOS CONTRA O TUMOR |
| 52/102 | US=64 / Câncer Badros A. Thalidomide in patients with relapsed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 205-27. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TALIDOMIDA EM PACIENTES MIELOMA MULTIPLO; TALIDOMIDA E MIELOMA |
| 53/102 | US=64 / Câncer Buadi FK, Rajkumar SV. Thalidomide: induction therapy. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 229-37. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TALIDOMIDA; TERAPIA DE INDUCAO; MIELOMA MULTIPLO; CLONAL DE CELULAS ESTAMINAIS |
| 54/102 | US=64 / Câncer Richardson PG, Mitsiades CS, Schlossman R, Hideshima T, Ghobrial I, Munshi NC, Anderson KC. The role of bortezomib in the treatment of relapsed and refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 239-52. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 55/102 | US=64 / Câncer San MFJ, Mateos MV. Bortezomib as induction therapy in patients with multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 253-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4. BORTEZOMIB; PACIENTES COM MIELOMA MULTIPLO. TERAPIA DE INDUCAO |
| 56/102 | US=64 / Câncer Yhomas SK, Richards TA, Weber DM. Lenalidomide in relapsed or refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 265-77. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA EM RECIDIVA; MIELOMA MULTIPLO REFRACTARIO; ESTEROIDES; ANTRACICLINAS |
| 57/102 | US=64 / Câncer Kumar S. Lenalidomide for initial therapy of newly diagnosed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 279-88. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA. TERAPIA COM MIELOMA MULTIPLO; MALIGNIDADE HEMATOLOGICA. LINFOMA NAO-HODGKIN |
| 58/102 | US=64 / Câncer Mitsiades CS, Hideshima T, Munshi NC, Richardson PG, Anderson KC. The role of heat shock protein 90 as a therapeutic target for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 291-308. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPEUTICO PARA O MIELOMA MULTIPLO; CHAPERONE MOLECULAR UBIQUAMENTE |
| 59/102 | US=64 / Câncer Harvey RD, Silberman J, Lonmial S. The PI3 kinase/akt pathway as a therapeutic target in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 309-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4. PI3 QUINASE; AKT; TERAPEUTICO NO MIELOMA MULTIPLO; MIELOMA MULTIPLO. TERAPIAS |
| 60/102 | US=64 / Câncer Frost P, Lichtenstein A. The mammalian target of rapamycin and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 323-30. (Comtemporary Hematology) ISBN 978-1-934115-82-4. RAPAMICINA EM MAMIFEROS; MIELOMA MULTIPLO; CELULAS EUCARIOTICAS; IMUNO-HISTOQUIMICA |